nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—RIPK2—ulcerative colitis	0.34	0.568	CbGaD
Crizotinib—JAK2—ulcerative colitis	0.23	0.383	CbGaD
Crizotinib—ABCB1—ulcerative colitis	0.0294	0.0491	CbGaD
Crizotinib—CYP3A4—Budesonide—ulcerative colitis	0.00669	0.114	CbGbCtD
Crizotinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.00581	0.0988	CbGbCtD
Crizotinib—ABCB1—Methylprednisolone—ulcerative colitis	0.00499	0.0848	CbGbCtD
Crizotinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.00466	0.0792	CbGbCtD
Crizotinib—ABCB1—Betamethasone—ulcerative colitis	0.00324	0.0551	CbGbCtD
Crizotinib—ABCB1—Prednisolone—ulcerative colitis	0.0032	0.0544	CbGbCtD
Crizotinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00303	0.0516	CbGbCtD
Crizotinib—ABCB1—Prednisone—ulcerative colitis	0.00302	0.0514	CbGbCtD
Crizotinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00299	0.0508	CbGbCtD
Crizotinib—CYP3A4—Nicotine—ulcerative colitis	0.00291	0.0495	CbGbCtD
Crizotinib—CYP3A5—Dexamethasone—ulcerative colitis	0.0029	0.0493	CbGbCtD
Crizotinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00261	0.0444	CbGbCtD
Crizotinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00226	0.0385	CbGbCtD
Crizotinib—CYP3A4—Betamethasone—ulcerative colitis	0.00194	0.033	CbGbCtD
Crizotinib—CYP3A4—Prednisolone—ulcerative colitis	0.00192	0.0326	CbGbCtD
Crizotinib—ABCB1—Dexamethasone—ulcerative colitis	0.00189	0.0321	CbGbCtD
Crizotinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00182	0.0309	CbGbCtD
Crizotinib—CYP3A4—Prednisone—ulcerative colitis	0.00181	0.0308	CbGbCtD
Crizotinib—PRKD1—smooth muscle tissue—ulcerative colitis	0.00125	0.0158	CbGeAlD
Crizotinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00113	0.0192	CbGbCtD
Crizotinib—NEK9—lymphoid tissue—ulcerative colitis	0.00109	0.0139	CbGeAlD
Crizotinib—NEK9—digestive system—ulcerative colitis	0.00108	0.0137	CbGeAlD
Crizotinib—MET—epithelium—ulcerative colitis	0.00108	0.0137	CbGeAlD
Crizotinib—PRKD1—digestive system—ulcerative colitis	0.000984	0.0125	CbGeAlD
Crizotinib—BLK—lymphoid tissue—ulcerative colitis	0.000924	0.0117	CbGeAlD
Crizotinib—MAPK7—lymphoid tissue—ulcerative colitis	0.000885	0.0112	CbGeAlD
Crizotinib—TXK—lymphoid tissue—ulcerative colitis	0.000885	0.0112	CbGeAlD
Crizotinib—BMPR1B—epithelium—ulcerative colitis	0.000862	0.011	CbGeAlD
Crizotinib—IGF1R—epithelium—ulcerative colitis	0.000845	0.0107	CbGeAlD
Crizotinib—MET—lymphoid tissue—ulcerative colitis	0.000828	0.0105	CbGeAlD
Crizotinib—TIE1—epithelium—ulcerative colitis	0.000822	0.0104	CbGeAlD
Crizotinib—MET—digestive system—ulcerative colitis	0.000818	0.0104	CbGeAlD
Crizotinib—IGF1R—smooth muscle tissue—ulcerative colitis	0.000814	0.0103	CbGeAlD
Crizotinib—NEK9—liver—ulcerative colitis	0.000804	0.0102	CbGeAlD
Crizotinib—CDK7—lymphoid tissue—ulcerative colitis	0.000801	0.0102	CbGeAlD
Crizotinib—TIE1—smooth muscle tissue—ulcerative colitis	0.000792	0.0101	CbGeAlD
Crizotinib—JAK3—lymphoid tissue—ulcerative colitis	0.00073	0.00928	CbGeAlD
Crizotinib—SIK2—liver—ulcerative colitis	0.000723	0.00919	CbGeAlD
Crizotinib—JAK3—digestive system—ulcerative colitis	0.000721	0.00917	CbGeAlD
Crizotinib—PLK4—lymphoid tissue—ulcerative colitis	0.000721	0.00917	CbGeAlD
Crizotinib—DCLK1—digestive system—ulcerative colitis	0.000717	0.00911	CbGeAlD
Crizotinib—STK4—lymphoid tissue—ulcerative colitis	0.000717	0.00911	CbGeAlD
Crizotinib—STK4—digestive system—ulcerative colitis	0.000708	0.009	CbGeAlD
Crizotinib—PRKD3—liver—ulcerative colitis	0.000705	0.00896	CbGeAlD
Crizotinib—ALK—lymphoid tissue—ulcerative colitis	0.000677	0.00861	CbGeAlD
Crizotinib—FER—lymphoid tissue—ulcerative colitis	0.000677	0.00861	CbGeAlD
Crizotinib—TYRO3—lymphoid tissue—ulcerative colitis	0.000677	0.00861	CbGeAlD
Crizotinib—RIPK2—epithelium—ulcerative colitis	0.000676	0.00859	CbGeAlD
Crizotinib—LYN—lymphoid tissue—ulcerative colitis	0.000674	0.00857	CbGeAlD
Crizotinib—CASK—liver—ulcerative colitis	0.000672	0.00854	CbGeAlD
Crizotinib—EPHA5—digestive system—ulcerative colitis	0.000669	0.00851	CbGeAlD
Crizotinib—ALK—digestive system—ulcerative colitis	0.000669	0.00851	CbGeAlD
Crizotinib—MAP4K1—lymphoid tissue—ulcerative colitis	0.000664	0.00844	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—ulcerative colitis	0.000656	0.00834	CbGeAlD
Crizotinib—IGF1R—lymphoid tissue—ulcerative colitis	0.000651	0.00827	CbGeAlD
Crizotinib—FES—liver—ulcerative colitis	0.000644	0.00819	CbGeAlD
Crizotinib—IGF1R—digestive system—ulcerative colitis	0.000643	0.00817	CbGeAlD
Crizotinib—MAP4K2—lymphoid tissue—ulcerative colitis	0.000642	0.00816	CbGeAlD
Crizotinib—PTK2—epithelium—ulcerative colitis	0.000627	0.00797	CbGeAlD
Crizotinib—AURKA—lymphoid tissue—ulcerative colitis	0.000617	0.00784	CbGeAlD
Crizotinib—AURKA—digestive system—ulcerative colitis	0.00061	0.00775	CbGeAlD
Crizotinib—MET—liver—ulcerative colitis	0.000609	0.00775	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—ulcerative colitis	0.000604	0.00768	CbGeAlD
Crizotinib—RPS6KB1—epithelium—ulcerative colitis	0.000603	0.00767	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—ulcerative colitis	0.0006	0.00763	CbGeAlD
Crizotinib—MERTK—lymphoid tissue—ulcerative colitis	0.000595	0.00757	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—ulcerative colitis	0.000593	0.00753	CbGeAlD
Crizotinib—CDK7—liver—ulcerative colitis	0.000589	0.00749	CbGeAlD
Crizotinib—TAOK2—liver—ulcerative colitis	0.000585	0.00743	CbGeAlD
Crizotinib—LIMK2—lymphoid tissue—ulcerative colitis	0.000582	0.0074	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—ulcerative colitis	0.000581	0.00739	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—ulcerative colitis	0.000576	0.00732	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—ulcerative colitis	0.000576	0.00732	CbGeAlD
Crizotinib—EPHB4—epithelium—ulcerative colitis	0.000571	0.00726	CbGeAlD
Crizotinib—JAK2—epithelium—ulcerative colitis	0.000567	0.0072	CbGeAlD
Crizotinib—ACVR1B—liver—ulcerative colitis	0.000563	0.00716	CbGeAlD
Crizotinib—EPHA2—epithelium—ulcerative colitis	0.00056	0.00712	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—ulcerative colitis	0.00055	0.00699	CbGeAlD
Crizotinib—TEK—epithelium—ulcerative colitis	0.000546	0.00694	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—ulcerative colitis	0.000546	0.00694	CbGeAlD
Crizotinib—STK4—liver—ulcerative colitis	0.000527	0.0067	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—ulcerative colitis	0.000526	0.00669	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—ulcerative colitis	0.000526	0.00669	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—ulcerative colitis	0.000525	0.00667	CbGeAlD
Crizotinib—PTK2B—digestive system—ulcerative colitis	0.000518	0.00659	CbGeAlD
Crizotinib—RIPK2—digestive system—ulcerative colitis	0.000514	0.00653	CbGeAlD
Crizotinib—FER—liver—ulcerative colitis	0.000499	0.00634	CbGeAlD
Crizotinib—LYN—liver—ulcerative colitis	0.000496	0.0063	CbGeAlD
Crizotinib—TNK1—liver—ulcerative colitis	0.000493	0.00627	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—ulcerative colitis	0.000493	0.00627	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—ulcerative colitis	0.000486	0.00618	CbGeAlD
Crizotinib—SRC—epithelium—ulcerative colitis	0.000485	0.00617	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—ulcerative colitis	0.000483	0.00614	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—ulcerative colitis	0.000483	0.00614	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—ulcerative colitis	0.00048	0.0061	CbGeAlD
Crizotinib—TNK2—liver—ulcerative colitis	0.000479	0.00609	CbGeAlD
Crizotinib—IGF1R—liver—ulcerative colitis	0.000479	0.00609	CbGeAlD
Crizotinib—TBK1—digestive system—ulcerative colitis	0.000477	0.00606	CbGeAlD
Crizotinib—PTK2—digestive system—ulcerative colitis	0.000477	0.00606	CbGeAlD
Crizotinib—TYK2—digestive system—ulcerative colitis	0.000474	0.00602	CbGeAlD
Crizotinib—MAP4K2—liver—ulcerative colitis	0.000472	0.006	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—ulcerative colitis	0.000468	0.00594	CbGeAlD
Crizotinib—TIE1—liver—ulcerative colitis	0.000466	0.00592	CbGeAlD
Crizotinib—STK3—liver—ulcerative colitis	0.000466	0.00592	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—ulcerative colitis	0.000465	0.00591	CbGeAlD
Crizotinib—FGR—lymphoid tissue—ulcerative colitis	0.000462	0.00587	CbGeAlD
Crizotinib—AXL—lymphoid tissue—ulcerative colitis	0.00046	0.00585	CbGeAlD
Crizotinib—RPS6KB1—digestive system—ulcerative colitis	0.000459	0.00583	CbGeAlD
Crizotinib—FGR—digestive system—ulcerative colitis	0.000456	0.0058	CbGeAlD
Crizotinib—AURKA—liver—ulcerative colitis	0.000454	0.00577	CbGeAlD
Crizotinib—TESK1—liver—ulcerative colitis	0.00045	0.00572	CbGeAlD
Crizotinib—MERTK—liver—ulcerative colitis	0.000438	0.00557	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—ulcerative colitis	0.000437	0.00555	CbGeAlD
Crizotinib—EPHB4—digestive system—ulcerative colitis	0.000434	0.00552	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—ulcerative colitis	0.000431	0.00548	CbGeAlD
Crizotinib—JAK2—digestive system—ulcerative colitis	0.000431	0.00548	CbGeAlD
Crizotinib—LIMK2—liver—ulcerative colitis	0.000428	0.00545	CbGeAlD
Crizotinib—NUAK2—liver—ulcerative colitis	0.000427	0.00543	CbGeAlD
Crizotinib—EPHA2—digestive system—ulcerative colitis	0.000426	0.00541	CbGeAlD
Crizotinib—ACVR1—liver—ulcerative colitis	0.000424	0.00539	CbGeAlD
Crizotinib—MAP3K12—liver—ulcerative colitis	0.000424	0.00539	CbGeAlD
Crizotinib—FLT3—liver—ulcerative colitis	0.000424	0.00539	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—ulcerative colitis	0.000421	0.00535	CbGeAlD
Crizotinib—TEK—lymphoid tissue—ulcerative colitis	0.000421	0.00535	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—ulcerative colitis	0.00042	0.00534	CbGeAlD
Crizotinib—STK35—liver—ulcerative colitis	0.000415	0.00528	CbGeAlD
Crizotinib—ABL2—liver—ulcerative colitis	0.000405	0.00514	CbGeAlD
Crizotinib—BMP2K—liver—ulcerative colitis	0.0004	0.00508	CbGeAlD
Crizotinib—YES1—lymphoid tissue—ulcerative colitis	0.000389	0.00494	CbGeAlD
Crizotinib—PTK2B—liver—ulcerative colitis	0.000386	0.00491	CbGeAlD
Crizotinib—STK10—lymphoid tissue—ulcerative colitis	0.000385	0.00489	CbGeAlD
Crizotinib—YES1—digestive system—ulcerative colitis	0.000384	0.00488	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—ulcerative colitis	0.000384	0.00488	CbGeAlD
Crizotinib—RIPK2—liver—ulcerative colitis	0.000383	0.00487	CbGeAlD
Crizotinib—STK10—digestive system—ulcerative colitis	0.00038	0.00483	CbGeAlD
Crizotinib—TAOK3—digestive system—ulcerative colitis	0.000379	0.00482	CbGeAlD
Crizotinib—SRC—lymphoid tissue—ulcerative colitis	0.000374	0.00475	CbGeAlD
Crizotinib—SRC—digestive system—ulcerative colitis	0.000369	0.00469	CbGeAlD
Crizotinib—MAP3K2—liver—ulcerative colitis	0.000363	0.00461	CbGeAlD
Crizotinib—TBK1—liver—ulcerative colitis	0.000356	0.00452	CbGeAlD
Crizotinib—PTK2—liver—ulcerative colitis	0.000356	0.00452	CbGeAlD
Crizotinib—TYK2—liver—ulcerative colitis	0.000353	0.00449	CbGeAlD
Crizotinib—IRAK1—liver—ulcerative colitis	0.000349	0.00443	CbGeAlD
Crizotinib—RPS6KB1—liver—ulcerative colitis	0.000342	0.00435	CbGeAlD
Crizotinib—LCK—liver—ulcerative colitis	0.00034	0.00432	CbGeAlD
Crizotinib—FGR—liver—ulcerative colitis	0.00034	0.00432	CbGeAlD
Crizotinib—AXL—liver—ulcerative colitis	0.000339	0.0043	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—ulcerative colitis	0.000336	0.00427	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000332	0.00422	CbGeAlD
Crizotinib—CSF1R—digestive system—ulcerative colitis	0.000332	0.00421	CbGeAlD
Crizotinib—AURKA—Calcipotriol—Cholecalciferol—ulcerative colitis	0.000329	0.103	CbGdCrCtD
Crizotinib—SLK—liver—ulcerative colitis	0.000326	0.00414	CbGeAlD
Crizotinib—EPHB4—liver—ulcerative colitis	0.000324	0.00411	CbGeAlD
Crizotinib—JAK2—liver—ulcerative colitis	0.000321	0.00408	CbGeAlD
Crizotinib—EPHA2—liver—ulcerative colitis	0.000317	0.00403	CbGeAlD
Crizotinib—MAP3K3—liver—ulcerative colitis	0.00031	0.00394	CbGeAlD
Crizotinib—TEK—liver—ulcerative colitis	0.00031	0.00394	CbGeAlD
Crizotinib—MAP4K5—liver—ulcerative colitis	0.00031	0.00394	CbGeAlD
Crizotinib—YES1—liver—ulcerative colitis	0.000286	0.00363	CbGeAlD
Crizotinib—STK10—liver—ulcerative colitis	0.000283	0.0036	CbGeAlD
Crizotinib—TAOK3—liver—ulcerative colitis	0.000282	0.00359	CbGeAlD
Crizotinib—SRC—liver—ulcerative colitis	0.000275	0.0035	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—ulcerative colitis	0.000265	0.00337	CbGeAlD
Crizotinib—ABL1—digestive system—ulcerative colitis	0.000262	0.00333	CbGeAlD
Crizotinib—CSF1R—liver—ulcerative colitis	0.000247	0.00314	CbGeAlD
Crizotinib—ACVR1—Dexamethasone—Budesonide—ulcerative colitis	0.000228	0.0716	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Budesonide—ulcerative colitis	0.000228	0.0716	CbGdCrCtD
Crizotinib—Infection—Budesonide—ulcerative colitis	0.000198	0.00237	CcSEcCtD
Crizotinib—Shock—Budesonide—ulcerative colitis	0.000196	0.00234	CcSEcCtD
Crizotinib—Nervous system disorder—Budesonide—ulcerative colitis	0.000196	0.00234	CcSEcCtD
Crizotinib—Leukopenia—Azathioprine—ulcerative colitis	0.000195	0.00233	CcSEcCtD
Crizotinib—ABL1—liver—ulcerative colitis	0.000195	0.00248	CbGeAlD
Crizotinib—Muscular weakness—Triamcinolone—ulcerative colitis	0.000195	0.00233	CcSEcCtD
Crizotinib—Dysgeusia—Mesalazine—ulcerative colitis	0.000195	0.00232	CcSEcCtD
Crizotinib—Muscular weakness—Methylprednisolone—ulcerative colitis	0.000195	0.00232	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.000195	0.00232	CcSEcCtD
Crizotinib—Skin disorder—Budesonide—ulcerative colitis	0.000194	0.00231	CcSEcCtD
Crizotinib—Dizziness—Nicotine—ulcerative colitis	0.000192	0.00229	CcSEcCtD
Crizotinib—Vomiting—Mercaptopurine—ulcerative colitis	0.00019	0.00227	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000189	0.00225	CcSEcCtD
Crizotinib—Rash—Mercaptopurine—ulcerative colitis	0.000189	0.00225	CcSEcCtD
Crizotinib—Dermatitis—Mercaptopurine—ulcerative colitis	0.000188	0.00225	CcSEcCtD
Crizotinib—Vision blurred—Mesalazine—ulcerative colitis	0.000187	0.00224	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000185	0.0022	CcSEcCtD
Crizotinib—Vomiting—Nicotine—ulcerative colitis	0.000184	0.0022	CcSEcCtD
Crizotinib—Anaemia—Mesalazine—ulcerative colitis	0.000184	0.00219	CcSEcCtD
Crizotinib—Weight decreased—Hydrocortisone—ulcerative colitis	0.000184	0.00219	CcSEcCtD
Crizotinib—Rash—Nicotine—ulcerative colitis	0.000183	0.00218	CcSEcCtD
Crizotinib—Hypokalaemia—Betamethasone—ulcerative colitis	0.000183	0.00218	CcSEcCtD
Crizotinib—Hypokalaemia—Dexamethasone—ulcerative colitis	0.000183	0.00218	CcSEcCtD
Crizotinib—Dermatitis—Nicotine—ulcerative colitis	0.000183	0.00218	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisolone—ulcerative colitis	0.000182	0.00217	CcSEcCtD
Crizotinib—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000181	0.00216	CcSEcCtD
Crizotinib—Infestation—Hydrocortisone—ulcerative colitis	0.000181	0.00216	CcSEcCtD
Crizotinib—Paraesthesia—Budesonide—ulcerative colitis	0.000179	0.00214	CcSEcCtD
Crizotinib—Syncope—Mesalazine—ulcerative colitis	0.000178	0.00213	CcSEcCtD
Crizotinib—Leukopenia—Mesalazine—ulcerative colitis	0.000178	0.00212	CcSEcCtD
Crizotinib—Dyspnoea—Budesonide—ulcerative colitis	0.000178	0.00212	CcSEcCtD
Crizotinib—Nausea—Mercaptopurine—ulcerative colitis	0.000178	0.00212	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000178	0.00212	CcSEcCtD
Crizotinib—Neuropathy peripheral—Hydrocortisone—ulcerative colitis	0.000177	0.00212	CcSEcCtD
Crizotinib—Infection—Azathioprine—ulcerative colitis	0.000177	0.00211	CcSEcCtD
Crizotinib—Muscular weakness—Dexamethasone—ulcerative colitis	0.000177	0.00211	CcSEcCtD
Crizotinib—Muscular weakness—Betamethasone—ulcerative colitis	0.000177	0.00211	CcSEcCtD
Crizotinib—Dyspepsia—Budesonide—ulcerative colitis	0.000176	0.0021	CcSEcCtD
Crizotinib—Loss of consciousness—Mesalazine—ulcerative colitis	0.000175	0.00209	CcSEcCtD
Crizotinib—Decreased appetite—Budesonide—ulcerative colitis	0.000173	0.00207	CcSEcCtD
Crizotinib—Skin disorder—Azathioprine—ulcerative colitis	0.000173	0.00207	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000172	0.00206	CcSEcCtD
Crizotinib—Nausea—Nicotine—ulcerative colitis	0.000172	0.00205	CcSEcCtD
Crizotinib—Fatigue—Budesonide—ulcerative colitis	0.000172	0.00205	CcSEcCtD
Crizotinib—Constipation—Budesonide—ulcerative colitis	0.000171	0.00204	CcSEcCtD
Crizotinib—Infestation—Methylprednisolone—ulcerative colitis	0.00017	0.00203	CcSEcCtD
Crizotinib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.00017	0.00203	CcSEcCtD
Crizotinib—Bradycardia—Prednisolone—ulcerative colitis	0.000169	0.00202	CcSEcCtD
Crizotinib—Face oedema—Prednisone—ulcerative colitis	0.000169	0.00201	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000168	0.00201	CcSEcCtD
Crizotinib—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000167	0.00199	CcSEcCtD
Crizotinib—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000167	0.00199	CcSEcCtD
Crizotinib—Bradycardia—Hydrocortisone—ulcerative colitis	0.000165	0.00197	CcSEcCtD
Crizotinib—Oedema—Mesalazine—ulcerative colitis	0.000162	0.00194	CcSEcCtD
Crizotinib—Infection—Mesalazine—ulcerative colitis	0.000161	0.00192	CcSEcCtD
Crizotinib—Visual impairment—Prednisolone—ulcerative colitis	0.00016	0.00191	CcSEcCtD
Crizotinib—Shock—Mesalazine—ulcerative colitis	0.00016	0.00191	CcSEcCtD
Crizotinib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000159	0.0019	CcSEcCtD
Crizotinib—Hypokalaemia—Prednisone—ulcerative colitis	0.000159	0.0019	CcSEcCtD
Crizotinib—Body temperature increased—Budesonide—ulcerative colitis	0.000158	0.00188	CcSEcCtD
Crizotinib—Skin disorder—Mesalazine—ulcerative colitis	0.000158	0.00188	CcSEcCtD
Crizotinib—Weight decreased—Dexamethasone—ulcerative colitis	0.000157	0.00187	CcSEcCtD
Crizotinib—Weight decreased—Betamethasone—ulcerative colitis	0.000157	0.00187	CcSEcCtD
Crizotinib—Bradycardia—Triamcinolone—ulcerative colitis	0.000156	0.00186	CcSEcCtD
Crizotinib—Bradycardia—Methylprednisolone—ulcerative colitis	0.000155	0.00185	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000154	0.00184	CcSEcCtD
Crizotinib—Muscular weakness—Prednisone—ulcerative colitis	0.000154	0.00184	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000154	0.00184	CcSEcCtD
Crizotinib—CYP3A5—digestive system—ulcerative colitis	0.000153	0.00195	CbGeAlD
Crizotinib—Eye disorder—Hydrocortisone—ulcerative colitis	0.000152	0.00181	CcSEcCtD
Crizotinib—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000152	0.00181	CcSEcCtD
Crizotinib—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000152	0.00181	CcSEcCtD
Crizotinib—Arrhythmia—Prednisolone—ulcerative colitis	0.000149	0.00177	CcSEcCtD
Crizotinib—Visual impairment—Methylprednisolone—ulcerative colitis	0.000147	0.00175	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Budesonide—ulcerative colitis	0.000147	0.0462	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Budesonide—ulcerative colitis	0.000147	0.0462	CbGdCrCtD
Crizotinib—Paraesthesia—Mesalazine—ulcerative colitis	0.000146	0.00174	CcSEcCtD
Crizotinib—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000145	0.00173	CcSEcCtD
Crizotinib—Dyspnoea—Mesalazine—ulcerative colitis	0.000145	0.00173	CcSEcCtD
Crizotinib—Asthenia—Budesonide—ulcerative colitis	0.000143	0.00171	CcSEcCtD
Crizotinib—Dyspepsia—Mesalazine—ulcerative colitis	0.000143	0.0017	CcSEcCtD
Crizotinib—Eye disorder—Methylprednisolone—ulcerative colitis	0.000143	0.0017	CcSEcCtD
Crizotinib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000142	0.00169	CcSEcCtD
Crizotinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000141	0.00169	CcSEcCtD
Crizotinib—Bradycardia—Betamethasone—ulcerative colitis	0.000141	0.00169	CcSEcCtD
Crizotinib—Bradycardia—Dexamethasone—ulcerative colitis	0.000141	0.00169	CcSEcCtD
Crizotinib—Neutropenia—Prednisone—ulcerative colitis	0.000141	0.00168	CcSEcCtD
Crizotinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000141	0.00168	CcSEcCtD
Crizotinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000141	0.00168	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00014	0.00167	CcSEcCtD
Crizotinib—Fatigue—Mesalazine—ulcerative colitis	0.00014	0.00167	CcSEcCtD
Crizotinib—Constipation—Mesalazine—ulcerative colitis	0.000139	0.00166	CcSEcCtD
Crizotinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000138	0.00164	CcSEcCtD
Crizotinib—Arrhythmia—Triamcinolone—ulcerative colitis	0.000137	0.00163	CcSEcCtD
Crizotinib—Weight decreased—Prednisone—ulcerative colitis	0.000137	0.00163	CcSEcCtD
Crizotinib—Diarrhoea—Budesonide—ulcerative colitis	0.000137	0.00163	CcSEcCtD
Crizotinib—Vision blurred—Prednisolone—ulcerative colitis	0.000136	0.00163	CcSEcCtD
Crizotinib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000136	0.00163	CcSEcCtD
Crizotinib—Visual impairment—Dexamethasone—ulcerative colitis	0.000134	0.0016	CcSEcCtD
Crizotinib—Visual impairment—Betamethasone—ulcerative colitis	0.000134	0.0016	CcSEcCtD
Crizotinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000133	0.00159	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000132	0.00157	CcSEcCtD
Crizotinib—Dizziness—Budesonide—ulcerative colitis	0.000132	0.00157	CcSEcCtD
Crizotinib—Dysgeusia—Triamcinolone—ulcerative colitis	0.00013	0.00156	CcSEcCtD
Crizotinib—Syncope—Prednisolone—ulcerative colitis	0.00013	0.00155	CcSEcCtD
Crizotinib—Eye disorder—Dexamethasone—ulcerative colitis	0.00013	0.00155	CcSEcCtD
Crizotinib—Eye disorder—Betamethasone—ulcerative colitis	0.00013	0.00155	CcSEcCtD
Crizotinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000128	0.00153	CcSEcCtD
Crizotinib—Loss of consciousness—Prednisolone—ulcerative colitis	0.000127	0.00152	CcSEcCtD
Crizotinib—Vomiting—Budesonide—ulcerative colitis	0.000127	0.00151	CcSEcCtD
Crizotinib—Syncope—Hydrocortisone—ulcerative colitis	0.000127	0.00151	CcSEcCtD
Crizotinib—Rash—Budesonide—ulcerative colitis	0.000126	0.0015	CcSEcCtD
Crizotinib—Dermatitis—Budesonide—ulcerative colitis	0.000126	0.0015	CcSEcCtD
Crizotinib—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000124	0.00148	CcSEcCtD
Crizotinib—Arrhythmia—Betamethasone—ulcerative colitis	0.000124	0.00148	CcSEcCtD
Crizotinib—Arrhythmia—Dexamethasone—ulcerative colitis	0.000124	0.00148	CcSEcCtD
Crizotinib—Bradycardia—Prednisone—ulcerative colitis	0.000123	0.00147	CcSEcCtD
Crizotinib—Diarrhoea—Azathioprine—ulcerative colitis	0.000122	0.00145	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00012	0.00143	CcSEcCtD
Crizotinib—Syncope—Triamcinolone—ulcerative colitis	0.000119	0.00142	CcSEcCtD
Crizotinib—Syncope—Methylprednisolone—ulcerative colitis	0.000119	0.00142	CcSEcCtD
Crizotinib—Nausea—Budesonide—ulcerative colitis	0.000119	0.00141	CcSEcCtD
Crizotinib—Oedema—Prednisolone—ulcerative colitis	0.000118	0.00141	CcSEcCtD
Crizotinib—Dizziness—Azathioprine—ulcerative colitis	0.000118	0.00141	CcSEcCtD
Crizotinib—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000117	0.0014	CcSEcCtD
Crizotinib—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000117	0.00139	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000117	0.0367	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Hydrocortisone—ulcerative colitis	0.000117	0.0367	CbGdCrCtD
Crizotinib—Asthenia—Mesalazine—ulcerative colitis	0.000116	0.00139	CcSEcCtD
Crizotinib—Shock—Prednisolone—ulcerative colitis	0.000116	0.00139	CcSEcCtD
Crizotinib—Oedema—Hydrocortisone—ulcerative colitis	0.000115	0.00138	CcSEcCtD
Crizotinib—CYP3A4—digestive system—ulcerative colitis	0.000115	0.00146	CbGeAlD
Crizotinib—Infection—Hydrocortisone—ulcerative colitis	0.000115	0.00137	CcSEcCtD
Crizotinib—CYP3A5—liver—ulcerative colitis	0.000114	0.00145	CbGeAlD
Crizotinib—Shock—Hydrocortisone—ulcerative colitis	0.000114	0.00135	CcSEcCtD
Crizotinib—Vomiting—Azathioprine—ulcerative colitis	0.000113	0.00135	CcSEcCtD
Crizotinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000113	0.00135	CcSEcCtD
Crizotinib—Eye disorder—Prednisone—ulcerative colitis	0.000113	0.00135	CcSEcCtD
Crizotinib—Rash—Azathioprine—ulcerative colitis	0.000112	0.00134	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000112	0.00134	CcSEcCtD
Crizotinib—Dermatitis—Azathioprine—ulcerative colitis	0.000112	0.00134	CcSEcCtD
Crizotinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000112	0.00134	CcSEcCtD
Crizotinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000111	0.00132	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Methylprednisolone—ulcerative colitis	0.00011	0.0346	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Methylprednisolone—ulcerative colitis	0.00011	0.0346	CbGdCrCtD
Crizotinib—Oedema—Triamcinolone—ulcerative colitis	0.000109	0.0013	CcSEcCtD
Crizotinib—Syncope—Betamethasone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Crizotinib—Syncope—Dexamethasone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Dexamethasone—ulcerative colitis	0.000108	0.0341	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Betamethasone—ulcerative colitis	0.000108	0.0341	CbGdCrCtD
Crizotinib—Arrhythmia—Prednisone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Crizotinib—Infection—Triamcinolone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Crizotinib—Infection—Methylprednisolone—ulcerative colitis	0.000108	0.00129	CcSEcCtD
Crizotinib—Dizziness—Mesalazine—ulcerative colitis	0.000107	0.00128	CcSEcCtD
Crizotinib—ABCB1—epithelium—ulcerative colitis	0.000107	0.00136	CbGeAlD
Crizotinib—Shock—Triamcinolone—ulcerative colitis	0.000107	0.00128	CcSEcCtD
Crizotinib—Shock—Methylprednisolone—ulcerative colitis	0.000107	0.00127	CcSEcCtD
Crizotinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000106	0.00127	CcSEcCtD
Crizotinib—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000106	0.00127	CcSEcCtD
Crizotinib—Loss of consciousness—Betamethasone—ulcerative colitis	0.000106	0.00127	CcSEcCtD
Crizotinib—Paraesthesia—Prednisolone—ulcerative colitis	0.000106	0.00127	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Triamcinolone—ulcerative colitis	0.000106	0.0333	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Triamcinolone—ulcerative colitis	0.000106	0.0333	CbGdCrCtD
Crizotinib—Nausea—Azathioprine—ulcerative colitis	0.000106	0.00126	CcSEcCtD
Crizotinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000105	0.00126	CcSEcCtD
Crizotinib—Malnutrition—Prednisone—ulcerative colitis	0.000105	0.00126	CcSEcCtD
Crizotinib—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000104	0.00124	CcSEcCtD
Crizotinib—Vomiting—Mesalazine—ulcerative colitis	0.000103	0.00123	CcSEcCtD
Crizotinib—Rash—Mesalazine—ulcerative colitis	0.000102	0.00122	CcSEcCtD
Crizotinib—Dermatitis—Mesalazine—ulcerative colitis	0.000102	0.00122	CcSEcCtD
Crizotinib—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000102	0.00121	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Prednisone—ulcerative colitis	0.0001	0.0316	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Prednisone—ulcerative colitis	0.0001	0.0316	CbGdCrCtD
Crizotinib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.0001	0.0012	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.96e-05	0.00119	CcSEcCtD
Crizotinib—Fatigue—Hydrocortisone—ulcerative colitis	9.95e-05	0.00119	CcSEcCtD
Crizotinib—Vision blurred—Prednisone—ulcerative colitis	9.91e-05	0.00118	CcSEcCtD
Crizotinib—Oedema—Betamethasone—ulcerative colitis	9.86e-05	0.00118	CcSEcCtD
Crizotinib—Oedema—Dexamethasone—ulcerative colitis	9.86e-05	0.00118	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Prednisolone—ulcerative colitis	9.81e-05	0.0308	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Prednisolone—ulcerative colitis	9.81e-05	0.0308	CbGdCrCtD
Crizotinib—Infection—Betamethasone—ulcerative colitis	9.79e-05	0.00117	CcSEcCtD
Crizotinib—Infection—Dexamethasone—ulcerative colitis	9.79e-05	0.00117	CcSEcCtD
Crizotinib—Paraesthesia—Triamcinolone—ulcerative colitis	9.76e-05	0.00116	CcSEcCtD
Crizotinib—Paraesthesia—Methylprednisolone—ulcerative colitis	9.74e-05	0.00116	CcSEcCtD
Crizotinib—Anaemia—Prednisone—ulcerative colitis	9.72e-05	0.00116	CcSEcCtD
Crizotinib—Shock—Dexamethasone—ulcerative colitis	9.7e-05	0.00116	CcSEcCtD
Crizotinib—Shock—Betamethasone—ulcerative colitis	9.7e-05	0.00116	CcSEcCtD
Crizotinib—Dyspnoea—Triamcinolone—ulcerative colitis	9.69e-05	0.00116	CcSEcCtD
Crizotinib—Nervous system disorder—Betamethasone—ulcerative colitis	9.67e-05	0.00115	CcSEcCtD
Crizotinib—Nervous system disorder—Dexamethasone—ulcerative colitis	9.67e-05	0.00115	CcSEcCtD
Crizotinib—Nausea—Mesalazine—ulcerative colitis	9.64e-05	0.00115	CcSEcCtD
Crizotinib—Dyspepsia—Triamcinolone—ulcerative colitis	9.56e-05	0.00114	CcSEcCtD
Crizotinib—Dyspepsia—Methylprednisolone—ulcerative colitis	9.54e-05	0.00114	CcSEcCtD
Crizotinib—Syncope—Prednisone—ulcerative colitis	9.43e-05	0.00113	CcSEcCtD
Crizotinib—Fatigue—Triamcinolone—ulcerative colitis	9.37e-05	0.00112	CcSEcCtD
Crizotinib—Fatigue—Methylprednisolone—ulcerative colitis	9.35e-05	0.00112	CcSEcCtD
Crizotinib—Loss of consciousness—Prednisone—ulcerative colitis	9.25e-05	0.0011	CcSEcCtD
Crizotinib—Body temperature increased—Hydrocortisone—ulcerative colitis	9.12e-05	0.00109	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	8.9e-05	0.00106	CcSEcCtD
Crizotinib—Paraesthesia—Betamethasone—ulcerative colitis	8.85e-05	0.00106	CcSEcCtD
Crizotinib—Paraesthesia—Dexamethasone—ulcerative colitis	8.85e-05	0.00106	CcSEcCtD
Crizotinib—Dyspepsia—Dexamethasone—ulcerative colitis	8.68e-05	0.00104	CcSEcCtD
Crizotinib—Dyspepsia—Betamethasone—ulcerative colitis	8.68e-05	0.00104	CcSEcCtD
Crizotinib—Body temperature increased—Triamcinolone—ulcerative colitis	8.59e-05	0.00103	CcSEcCtD
Crizotinib—Oedema—Prednisone—ulcerative colitis	8.59e-05	0.00102	CcSEcCtD
Crizotinib—CYP3A4—liver—ulcerative colitis	8.58e-05	0.00109	CbGeAlD
Crizotinib—Decreased appetite—Betamethasone—ulcerative colitis	8.57e-05	0.00102	CcSEcCtD
Crizotinib—Decreased appetite—Dexamethasone—ulcerative colitis	8.57e-05	0.00102	CcSEcCtD
Crizotinib—Infection—Prednisone—ulcerative colitis	8.53e-05	0.00102	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.51e-05	0.00102	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.51e-05	0.00102	CcSEcCtD
Crizotinib—Fatigue—Dexamethasone—ulcerative colitis	8.5e-05	0.00101	CcSEcCtD
Crizotinib—Fatigue—Betamethasone—ulcerative colitis	8.5e-05	0.00101	CcSEcCtD
Crizotinib—Shock—Prednisone—ulcerative colitis	8.45e-05	0.00101	CcSEcCtD
Crizotinib—Nervous system disorder—Prednisone—ulcerative colitis	8.42e-05	0.001	CcSEcCtD
Crizotinib—Skin disorder—Prednisone—ulcerative colitis	8.34e-05	0.000995	CcSEcCtD
Crizotinib—Asthenia—Hydrocortisone—ulcerative colitis	8.28e-05	0.000988	CcSEcCtD
Crizotinib—ABCB1—lymphoid tissue—ulcerative colitis	8.25e-05	0.00105	CbGeAlD
Crizotinib—ABCB1—digestive system—ulcerative colitis	8.15e-05	0.00104	CbGeAlD
Crizotinib—Diarrhoea—Hydrocortisone—ulcerative colitis	7.9e-05	0.000942	CcSEcCtD
Crizotinib—Dizziness—Prednisolone—ulcerative colitis	7.81e-05	0.000932	CcSEcCtD
Crizotinib—Asthenia—Triamcinolone—ulcerative colitis	7.8e-05	0.00093	CcSEcCtD
Crizotinib—Body temperature increased—Dexamethasone—ulcerative colitis	7.79e-05	0.00093	CcSEcCtD
Crizotinib—Body temperature increased—Betamethasone—ulcerative colitis	7.79e-05	0.00093	CcSEcCtD
Crizotinib—Asthenia—Methylprednisolone—ulcerative colitis	7.78e-05	0.000928	CcSEcCtD
Crizotinib—Paraesthesia—Prednisone—ulcerative colitis	7.71e-05	0.00092	CcSEcCtD
Crizotinib—Dizziness—Hydrocortisone—ulcerative colitis	7.63e-05	0.000911	CcSEcCtD
Crizotinib—Dyspepsia—Prednisone—ulcerative colitis	7.56e-05	0.000902	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Hydrocortisone—ulcerative colitis	7.52e-05	0.0236	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Hydrocortisone—ulcerative colitis	7.52e-05	0.0236	CbGdCrCtD
Crizotinib—Decreased appetite—Prednisone—ulcerative colitis	7.46e-05	0.000891	CcSEcCtD
Crizotinib—Rash—Prednisolone—ulcerative colitis	7.45e-05	0.000889	CcSEcCtD
Crizotinib—Dermatitis—Prednisolone—ulcerative colitis	7.44e-05	0.000888	CcSEcCtD
Crizotinib—Diarrhoea—Methylprednisolone—ulcerative colitis	7.42e-05	0.000885	CcSEcCtD
Crizotinib—Fatigue—Prednisone—ulcerative colitis	7.4e-05	0.000883	CcSEcCtD
Crizotinib—Constipation—Prednisone—ulcerative colitis	7.34e-05	0.000876	CcSEcCtD
Crizotinib—Vomiting—Hydrocortisone—ulcerative colitis	7.34e-05	0.000876	CcSEcCtD
Crizotinib—Rash—Hydrocortisone—ulcerative colitis	7.28e-05	0.000868	CcSEcCtD
Crizotinib—Dermatitis—Hydrocortisone—ulcerative colitis	7.27e-05	0.000867	CcSEcCtD
Crizotinib—Dizziness—Triamcinolone—ulcerative colitis	7.19e-05	0.000857	CcSEcCtD
Crizotinib—Dizziness—Methylprednisolone—ulcerative colitis	7.17e-05	0.000856	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Methylprednisolone—ulcerative colitis	7.09e-05	0.0223	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Methylprednisolone—ulcerative colitis	7.09e-05	0.0223	CbGdCrCtD
Crizotinib—Asthenia—Dexamethasone—ulcerative colitis	7.07e-05	0.000844	CcSEcCtD
Crizotinib—Asthenia—Betamethasone—ulcerative colitis	7.07e-05	0.000844	CcSEcCtD
Crizotinib—Nausea—Prednisolone—ulcerative colitis	7.02e-05	0.000838	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Dexamethasone—ulcerative colitis	6.98e-05	0.0219	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Betamethasone—ulcerative colitis	6.98e-05	0.0219	CbGdCrCtD
Crizotinib—Vomiting—Triamcinolone—ulcerative colitis	6.91e-05	0.000824	CcSEcCtD
Crizotinib—Vomiting—Methylprednisolone—ulcerative colitis	6.89e-05	0.000823	CcSEcCtD
Crizotinib—Nausea—Hydrocortisone—ulcerative colitis	6.85e-05	0.000818	CcSEcCtD
Crizotinib—Rash—Triamcinolone—ulcerative colitis	6.85e-05	0.000818	CcSEcCtD
Crizotinib—Dermatitis—Triamcinolone—ulcerative colitis	6.84e-05	0.000817	CcSEcCtD
Crizotinib—Rash—Methylprednisolone—ulcerative colitis	6.84e-05	0.000816	CcSEcCtD
Crizotinib—Dermatitis—Methylprednisolone—ulcerative colitis	6.83e-05	0.000815	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Triamcinolone—ulcerative colitis	6.82e-05	0.0214	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Triamcinolone—ulcerative colitis	6.82e-05	0.0214	CbGdCrCtD
Crizotinib—Body temperature increased—Prednisone—ulcerative colitis	6.79e-05	0.00081	CcSEcCtD
Crizotinib—Diarrhoea—Dexamethasone—ulcerative colitis	6.75e-05	0.000805	CcSEcCtD
Crizotinib—Diarrhoea—Betamethasone—ulcerative colitis	6.75e-05	0.000805	CcSEcCtD
Crizotinib—Dizziness—Dexamethasone—ulcerative colitis	6.52e-05	0.000778	CcSEcCtD
Crizotinib—Dizziness—Betamethasone—ulcerative colitis	6.52e-05	0.000778	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Prednisone—ulcerative colitis	6.47e-05	0.0203	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Prednisone—ulcerative colitis	6.47e-05	0.0203	CbGdCrCtD
Crizotinib—Nausea—Triamcinolone—ulcerative colitis	6.45e-05	0.00077	CcSEcCtD
Crizotinib—Nausea—Methylprednisolone—ulcerative colitis	6.44e-05	0.000768	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Prednisolone—ulcerative colitis	6.32e-05	0.0199	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisolone—ulcerative colitis	6.32e-05	0.0199	CbGdCrCtD
Crizotinib—Vomiting—Betamethasone—ulcerative colitis	6.27e-05	0.000748	CcSEcCtD
Crizotinib—Vomiting—Dexamethasone—ulcerative colitis	6.27e-05	0.000748	CcSEcCtD
Crizotinib—Rash—Dexamethasone—ulcerative colitis	6.22e-05	0.000742	CcSEcCtD
Crizotinib—Rash—Betamethasone—ulcerative colitis	6.22e-05	0.000742	CcSEcCtD
Crizotinib—Dermatitis—Dexamethasone—ulcerative colitis	6.21e-05	0.000741	CcSEcCtD
Crizotinib—Dermatitis—Betamethasone—ulcerative colitis	6.21e-05	0.000741	CcSEcCtD
Crizotinib—Asthenia—Prednisone—ulcerative colitis	6.16e-05	0.000735	CcSEcCtD
Crizotinib—ABCB1—liver—ulcerative colitis	6.07e-05	0.000772	CbGeAlD
Crizotinib—Diarrhoea—Prednisone—ulcerative colitis	5.87e-05	0.000701	CcSEcCtD
Crizotinib—Nausea—Dexamethasone—ulcerative colitis	5.86e-05	0.000699	CcSEcCtD
Crizotinib—Nausea—Betamethasone—ulcerative colitis	5.86e-05	0.000699	CcSEcCtD
Crizotinib—Dizziness—Prednisone—ulcerative colitis	5.68e-05	0.000678	CcSEcCtD
Crizotinib—Vomiting—Prednisone—ulcerative colitis	5.46e-05	0.000651	CcSEcCtD
Crizotinib—Rash—Prednisone—ulcerative colitis	5.41e-05	0.000646	CcSEcCtD
Crizotinib—Dermatitis—Prednisone—ulcerative colitis	5.41e-05	0.000645	CcSEcCtD
Crizotinib—Nausea—Prednisone—ulcerative colitis	5.1e-05	0.000609	CcSEcCtD
Crizotinib—PTK2B—Signaling Pathways—CXCL8—ulcerative colitis	2.16e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADRB2—ulcerative colitis	2.15e-06	1.22e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—JAK2—ulcerative colitis	2.15e-06	1.21e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.15e-06	1.21e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TP53—ulcerative colitis	2.15e-06	1.21e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—STAT3—ulcerative colitis	2.14e-06	1.21e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL6—ulcerative colitis	2.14e-06	1.21e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—IL6—ulcerative colitis	2.14e-06	1.21e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—JAK2—ulcerative colitis	2.14e-06	1.21e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—RELA—ulcerative colitis	2.13e-06	1.2e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—IL6—ulcerative colitis	2.13e-06	1.2e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—IL6—ulcerative colitis	2.12e-06	1.2e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—STAT3—ulcerative colitis	2.11e-06	1.19e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—IL2—ulcerative colitis	2.11e-06	1.19e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IFNG—ulcerative colitis	2.11e-06	1.19e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL2—ulcerative colitis	2.1e-06	1.19e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NFKB1—ulcerative colitis	2.1e-06	1.19e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IFNG—ulcerative colitis	2.1e-06	1.19e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TLR4—ulcerative colitis	2.1e-06	1.18e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—ulcerative colitis	2.09e-06	1.18e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TP53—ulcerative colitis	2.09e-06	1.18e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	2.09e-06	1.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADCY5—ulcerative colitis	2.08e-06	1.18e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—RELA—ulcerative colitis	2.08e-06	1.18e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CXCL8—ulcerative colitis	2.07e-06	1.17e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—RELA—ulcerative colitis	2.07e-06	1.17e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL2—ulcerative colitis	2.07e-06	1.17e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TGFB1—ulcerative colitis	2.06e-06	1.16e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TP53—ulcerative colitis	2.05e-06	1.16e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—ulcerative colitis	2.04e-06	1.15e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—ulcerative colitis	2.03e-06	1.15e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—ulcerative colitis	2.02e-06	1.14e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—ICAM1—ulcerative colitis	2.01e-06	1.14e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CXCL8—ulcerative colitis	2.01e-06	1.14e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CDH1—ulcerative colitis	2.01e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CXCL8—ulcerative colitis	2.01e-06	1.13e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—STAT3—ulcerative colitis	2e-06	1.13e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—IL6—ulcerative colitis	2e-06	1.13e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—ulcerative colitis	1.99e-06	1.12e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—STAT3—ulcerative colitis	1.98e-06	1.12e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL2—ulcerative colitis	1.98e-06	1.12e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—ulcerative colitis	1.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NFKB1—ulcerative colitis	1.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—ulcerative colitis	1.96e-06	1.11e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—STAT3—ulcerative colitis	1.95e-06	1.1e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—RELA—ulcerative colitis	1.95e-06	1.1e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NFKB1—ulcerative colitis	1.94e-06	1.09e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—ulcerative colitis	1.92e-06	1.09e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL2—ulcerative colitis	1.92e-06	1.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL2—ulcerative colitis	1.92e-06	1.08e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—ulcerative colitis	1.91e-06	1.08e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—ulcerative colitis	1.91e-06	1.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—ulcerative colitis	1.91e-06	1.08e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADRB2—ulcerative colitis	1.9e-06	1.08e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—ulcerative colitis	1.89e-06	1.07e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—JAK2—ulcerative colitis	1.89e-06	1.07e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—ulcerative colitis	1.88e-06	1.06e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—ulcerative colitis	1.88e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TP53—ulcerative colitis	1.88e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—ulcerative colitis	1.88e-06	1.06e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—ulcerative colitis	1.87e-06	1.06e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—ulcerative colitis	1.87e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL2—ulcerative colitis	1.87e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—ulcerative colitis	1.87e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL2—ulcerative colitis	1.86e-06	1.05e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—JAK2—ulcerative colitis	1.86e-06	1.05e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—ulcerative colitis	1.85e-06	1.05e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—ulcerative colitis	1.85e-06	1.04e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—ulcerative colitis	1.84e-06	1.04e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—ulcerative colitis	1.84e-06	1.04e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—ulcerative colitis	1.83e-06	1.03e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RELA—ulcerative colitis	1.83e-06	1.03e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	1.83e-06	1.03e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—ulcerative colitis	1.82e-06	1.03e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RELA—ulcerative colitis	1.8e-06	1.02e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—ulcerative colitis	1.8e-06	1.02e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—STAT3—ulcerative colitis	1.8e-06	1.02e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CDH1—ulcerative colitis	1.78e-06	1e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—ulcerative colitis	1.77e-06	1e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—JAK2—ulcerative colitis	1.77e-06	9.98e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—STAT3—ulcerative colitis	1.77e-06	9.98e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—JAK2—ulcerative colitis	1.76e-06	9.95e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—ulcerative colitis	1.76e-06	9.94e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—ulcerative colitis	1.76e-06	9.94e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—ulcerative colitis	1.75e-06	9.91e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL2—ulcerative colitis	1.75e-06	9.91e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.75e-06	9.89e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—ulcerative colitis	1.75e-06	9.87e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—ulcerative colitis	1.75e-06	9.87e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—STAT3—ulcerative colitis	1.74e-06	9.84e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—ulcerative colitis	1.73e-06	9.76e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—ulcerative colitis	1.72e-06	9.74e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—JAK2—ulcerative colitis	1.71e-06	9.69e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RELA—ulcerative colitis	1.71e-06	9.67e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—RELA—ulcerative colitis	1.7e-06	9.63e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—ulcerative colitis	1.7e-06	9.6e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—ulcerative colitis	1.67e-06	9.43e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—STAT3—ulcerative colitis	1.67e-06	9.41e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—ulcerative colitis	1.67e-06	9.41e-06	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TP53—ulcerative colitis	1.66e-06	9.41e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RELA—ulcerative colitis	1.66e-06	9.38e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—ulcerative colitis	1.65e-06	9.31e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—ulcerative colitis	1.64e-06	9.28e-06	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.64e-06	9.25e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—ulcerative colitis	1.64e-06	9.25e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—JAK2—ulcerative colitis	1.63e-06	9.18e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.62e-06	9.18e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—ulcerative colitis	1.62e-06	9.18e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADCY5—ulcerative colitis	1.62e-06	9.13e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—STAT3—ulcerative colitis	1.62e-06	9.13e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—ulcerative colitis	1.61e-06	9.12e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—ulcerative colitis	1.61e-06	9.11e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—STAT3—ulcerative colitis	1.58e-06	8.91e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CALM3—ulcerative colitis	1.58e-06	8.91e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—STAT3—ulcerative colitis	1.57e-06	8.87e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—ulcerative colitis	1.56e-06	8.84e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—ulcerative colitis	1.56e-06	8.81e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—JAK2—ulcerative colitis	1.56e-06	8.81e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—ulcerative colitis	1.55e-06	8.78e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—ulcerative colitis	1.55e-06	8.76e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—ulcerative colitis	1.54e-06	8.73e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—ulcerative colitis	1.54e-06	8.71e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—ulcerative colitis	1.54e-06	8.71e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—ulcerative colitis	1.54e-06	8.71e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—ulcerative colitis	1.54e-06	8.7e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—ulcerative colitis	1.54e-06	8.69e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—ulcerative colitis	1.54e-06	8.68e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—ulcerative colitis	1.53e-06	8.64e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—ulcerative colitis	1.53e-06	8.64e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—ulcerative colitis	1.52e-06	8.59e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.52e-06	8.56e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TP53—ulcerative colitis	1.51e-06	8.54e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—RELA—ulcerative colitis	1.51e-06	8.53e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—ulcerative colitis	1.5e-06	8.46e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—ulcerative colitis	1.5e-06	8.46e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—ulcerative colitis	1.5e-06	8.45e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—ulcerative colitis	1.49e-06	8.41e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—ulcerative colitis	1.48e-06	8.35e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—ulcerative colitis	1.48e-06	8.34e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—STAT3—ulcerative colitis	1.47e-06	8.34e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—ulcerative colitis	1.46e-06	8.24e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—ulcerative colitis	1.44e-06	8.15e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—JAK2—ulcerative colitis	1.44e-06	8.13e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—ulcerative colitis	1.44e-06	8.12e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—ulcerative colitis	1.42e-06	8e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—ulcerative colitis	1.4e-06	7.91e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—ulcerative colitis	1.4e-06	7.91e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—JAK2—ulcerative colitis	1.39e-06	7.85e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—STAT3—ulcerative colitis	1.39e-06	7.83e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—ulcerative colitis	1.38e-06	7.82e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—ulcerative colitis	1.37e-06	7.75e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—STAT3—ulcerative colitis	1.37e-06	7.72e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—ulcerative colitis	1.36e-06	7.71e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—ulcerative colitis	1.36e-06	7.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—STAT3—ulcerative colitis	1.36e-06	7.7e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—ulcerative colitis	1.36e-06	7.68e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—ulcerative colitis	1.36e-06	7.68e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—ulcerative colitis	1.35e-06	7.65e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TP53—ulcerative colitis	1.35e-06	7.62e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RELA—ulcerative colitis	1.34e-06	7.6e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TP53—ulcerative colitis	1.33e-06	7.51e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—STAT3—ulcerative colitis	1.3e-06	7.33e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—STAT3—ulcerative colitis	1.29e-06	7.3e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—ulcerative colitis	1.28e-06	7.26e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—ulcerative colitis	1.27e-06	7.19e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—ulcerative colitis	1.27e-06	7.18e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	1.27e-06	7.16e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—ulcerative colitis	1.27e-06	7.16e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—ulcerative colitis	1.26e-06	7.13e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—STAT3—ulcerative colitis	1.26e-06	7.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RELA—ulcerative colitis	1.26e-06	7.11e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—ulcerative colitis	1.26e-06	7.09e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—ulcerative colitis	1.23e-06	6.97e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—ulcerative colitis	1.23e-06	6.97e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—ulcerative colitis	1.22e-06	6.87e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—ulcerative colitis	1.21e-06	6.84e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—ulcerative colitis	1.2e-06	6.79e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—STAT3—ulcerative colitis	1.19e-06	6.74e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—ulcerative colitis	1.19e-06	6.7e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—ulcerative colitis	1.17e-06	6.59e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—ulcerative colitis	1.16e-06	6.58e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—ulcerative colitis	1.15e-06	6.48e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—STAT3—ulcerative colitis	1.14e-06	6.46e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.14e-06	6.46e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—JAK2—ulcerative colitis	1.14e-06	6.43e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	1.13e-06	6.41e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—ulcerative colitis	1.13e-06	6.4e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.13e-06	6.39e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—ulcerative colitis	1.13e-06	6.38e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—ulcerative colitis	1.13e-06	6.37e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—ulcerative colitis	1.11e-06	6.25e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RELA—ulcerative colitis	1.1e-06	6.23e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—ulcerative colitis	1.1e-06	6.22e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—ulcerative colitis	1.1e-06	6.19e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.08e-06	6.09e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—ulcerative colitis	1.07e-06	6.06e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—ulcerative colitis	1.06e-06	6e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—ulcerative colitis	1.06e-06	5.98e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—STAT3—ulcerative colitis	1.06e-06	5.97e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—ulcerative colitis	1.04e-06	5.89e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	1.04e-06	5.87e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—ulcerative colitis	1.03e-06	5.82e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—STAT3—ulcerative colitis	1.02e-06	5.76e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—ulcerative colitis	1.02e-06	5.74e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—JAK2—ulcerative colitis	1.01e-06	5.69e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—ulcerative colitis	9.93e-07	5.61e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—ulcerative colitis	9.89e-07	5.59e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—ulcerative colitis	9.79e-07	5.53e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RELA—ulcerative colitis	9.76e-07	5.51e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	9.71e-07	5.49e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—ulcerative colitis	9.68e-07	5.47e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—ulcerative colitis	9.6e-07	5.43e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—ulcerative colitis	9.55e-07	5.39e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—STAT3—ulcerative colitis	9.54e-07	5.39e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—ulcerative colitis	9.51e-07	5.38e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	9.45e-07	5.34e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—ulcerative colitis	9.39e-07	5.31e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	9.29e-07	5.25e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—ulcerative colitis	9.19e-07	5.2e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—ulcerative colitis	9.05e-07	5.12e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—ulcerative colitis	9.02e-07	5.1e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	8.89e-07	5.02e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—ulcerative colitis	8.84e-07	5e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—ulcerative colitis	8.79e-07	4.97e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—ulcerative colitis	8.79e-07	4.97e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARG—ulcerative colitis	8.53e-07	4.82e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—STAT3—ulcerative colitis	8.35e-07	4.72e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—ulcerative colitis	8.33e-07	4.71e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—ulcerative colitis	8.32e-07	4.7e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—ulcerative colitis	8.23e-07	4.65e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—ulcerative colitis	7.99e-07	4.51e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—ulcerative colitis	7.78e-07	4.39e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	7.74e-07	4.38e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—ulcerative colitis	7.67e-07	4.33e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	7.55e-07	4.27e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—STAT3—ulcerative colitis	7.39e-07	4.18e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—ulcerative colitis	7.38e-07	4.17e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—ulcerative colitis	7.28e-07	4.11e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—ulcerative colitis	7.12e-07	4.02e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	7.04e-07	3.98e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—ulcerative colitis	6.85e-07	3.87e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	6.71e-07	3.79e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—ulcerative colitis	6.66e-07	3.76e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—ulcerative colitis	6.37e-07	3.6e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—ulcerative colitis	5.83e-07	3.3e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—ulcerative colitis	5.64e-07	3.19e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.25e-07	2.97e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—ulcerative colitis	5.16e-07	2.92e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—ulcerative colitis	4.72e-07	2.67e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	4.13e-07	2.34e-06	CbGpPWpGaD
